Cytokinetics, Incorporated Analysis
Analyst Ratings |
Average Target Price
|
62.07
|
Average Rating
|
4.40
|
# Strong Buys
|
6
|
# Buys
|
9
|
# Holds
|
0
|
# Sells
|
0
|
# Strong Sells
|
0
|
Quarterly Earnings History |
Quarter |
EPS Estimate |
EPS Actual |
EPS Difference |
Surprise Percent |
2022-09-30
|
-1.17
|
-1.52
|
-0.35
|
-29.91%
|
2022-06-30
|
-1.02
|
-0.23
|
0.79
|
77.45%
|
2022-03-31
|
-0.94
|
-1.05
|
-0.11
|
-11.70%
|
2021-12-31
|
-0.84
|
-0.36
|
0.48
|
57.14%
|
2021-09-30
|
-0.77
|
-0.95
|
-0.18
|
-23.38%
|
2021-06-30
|
-0.66
|
-0.86
|
-0.20
|
-30.30%
|
2021-03-31
|
-0.58
|
-0.66
|
-0.08
|
-13.79%
|
2020-12-31
|
-0.30
|
-0.62
|
-0.32
|
-106.67%
|
Annual Earnings History |
Fiscal Year End |
EPS |
2022-12-31
|
-2.80
|
2021-12-31
|
-2.83
|
2020-12-31
|
-2.01
|
2019-12-31
|
-2.12
|
2018-12-31
|
-1.95
|
2017-12-31
|
-2.57
|
2016-12-31
|
0.30
|
2015-12-31
|
-0.97
|
2014-12-31
|
-0.43
|
2013-12-31
|
-1.34
|
2012-12-31
|
-2.40
|
2011-12-31
|
-4.32
|
2010-12-31
|
-4.62
|
2009-12-31
|
2.58
|
2008-12-31
|
-6.84
|
2007-12-31
|
-6.18
|
2006-12-31
|
-9.30
|
2005-12-31
|
-8.82
|
2004-12-31
|
-8.79
|